Inventor · disambiguated record
Tivadar Tamas
Also filed as: TAMAS TIVADAR
6 granted patents·12 pending applications·10 citations·filing 2001–2018
75Inventor score
Files withMOLNAR SANDOR6TEVA GYOGYSZERGYAR ZARTKOERUEN3HAJKO JANOS2BIOGAL PHARMACEUTICAL CO LTD1SHINITZKY MEIR1
Top patents by PatentIndex Score
18 records- 0185US7439373B2Crystalline mycophenolate sodiumTEVA GYOGYSZERGYAR ZARTKOERUEN·Filed 2005·Granted Oct 21, 2008·4 cites·4 claims
- 0273US7358247B2Mycophenolate mofetil impurityTEVA GYOGYSZERGYAR ZARTKOERUEN·Filed 2005·Granted Apr 15, 2008·3 cites·20 claims
- 0367US2008097096A1Processes for preparation of crystalline mycophenolate sodiumMOLNAR SANDOR·Filed 2007·Application pending·0 cites
- 0457US2008103317A1Processes for preparation of crystalline mycophenolate sodiumMOLNAR SANDOR·Filed 2007·Application pending·0 cites
- 0556US7098345B2Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-oneTEVA GYOGYSZERGYAR ZARKOERUEEN·Filed 2003·Granted Aug 29, 2006·2 cites·22 claims
- 0656US2008280977A1Process for preparation of mycophenolate mofetil and other esters of mycophenolic acidMOLNAR SANDOR·Filed 2008·Application pending·0 cites
- 0756US2008281111A1Process for preparation of mycophenolate mofetil and other esters of mycophenolic acidMOLNAR SANDOR·Filed 2008·Application pending·0 cites
- 0854US8987263B2Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agentsSHINITZKY MEIR·Filed 2003·Granted Mar 24, 2015·1 cites·17 claims
- 0950US2006252942A1Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-oneMOLNAR SANDOR·Filed 2006·Application pending·0 cites
- 1048US2008241948A1Mycophenolate mofetil impurityMOLNAR SANDOR·Filed 2008·Application pending·0 cites
- 1147US2009030207A1Polymorphs of Dolasetron base and process for preparation thereofHAJKO JANOS·Filed 2008·Application pending·0 cites
- 1247US2009062546A1Dolasetron trifluoroacetate, polymorphs of dolasetron trifluoroacetate and process for preparation thereofHAJKO JANOS·Filed 2008·Application pending·0 cites
- 1346US7608714B2Production of dolasetronTEVA GYOGYSZERGYAR ZARTKOERUEN·Filed 2007·Granted Oct 27, 2009·0 cites·80 claims
- 1443US2008262060A1Crystalline forms of DeferasiroxTOTH ZOLTAN G·Filed 2008·Application pending·0 cites
- 1539US2005131045A1Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using themFiled 2004·Application pending·0 cites
- 1638US2004019093A1Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using themFiled 2003·Application pending·0 cites
- 1723US6610738B2N-disubstituted carbamoyloxy flavonesBIOGAL PHARMACEUTICAL CO LTD·Filed 2001·Granted Aug 26, 2003·0 cites·34 claims
- 1823US2020010481A1Solid state forms of midostaurinTEVA PHARMACEUTICAL WORKS LTD·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →